Rapport Therapeutics, Inc. Common Stock (RAPP) Financial Analysis & Valuation | Quarter Chart
Rapport Therapeutics, Inc. Common Stock (RAPP)
RAPPPrice: $26.48
Fair Value: 🔒
🔒score
Description
Shares
| Market Cap | $966.40M | Exchange | NASDAQ |
| Sector | — | Industry | — |
| Country | — | CEO | Abraham N. Ceesay |
| IPO Date | 2024-06-07 | CAGR | — |
| Employees | 69 | Website | — |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
RAPP chart loading...
Fundamentals
Technicals
| Enterprise Value | $1.38B | P/E Ratio | -12.26 |
| Forward P/E | -9.39 | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 2.57 |
| P/CF Ratio | -14.22 | P/FCF Ratio | -10.99 |
| EPS | $-2.27 | EPS Growth 1Y | 472.71% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | — | Gross Margin | — |
| Operating Margin | — | Profit Margin | — |
| ROE | -0.29% | ROA | -0.22% |
| ROCE | -0.25% | Current Ratio | 26.17 |
| Quick Ratio | 26.17 | Cash Ratio | 2.76 |
| Debt/Equity | 0.02 | Interest Coverage | — |
| Altman Z Score | 20.73 | Piotroski Score | 1 |
View Rapport Therapeutics, Inc. Common Stock financial charts →